HC Wainwright & Co. Reiterates Buy on 89bio, Maintains $35 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on 89bio (NASDAQ:ETNB) and maintained a $35 price target.
August 10, 2023 | 5:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
89bio's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $35.
The reiteration of a 'Buy' rating and maintenance of a $35 price target by HC Wainwright & Co. indicates a positive outlook for 89bio. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100